Search

Meeting Coverage:

Aspen Retinal Detachment Society

ARDS: 2016

Treatments Using Gene Therapy and Engineered Cells

Szilard Kiss, MD, Tim Murray, MD

Show Description +

Szilárd Kiss, MD, explains the most important portions of his presentation on ocular gene therapy to Tim Murray, MD, MBA. Dr. Kiss says that although the most immediate consequence of advancements in ocular gene therapy may affect patents with Leber congenital amaurosis, the possible benefits to patients with age-related macular degeneration and diabetic macular edema may serve large swaths of the population. Dr. Kiss also discusses the importance of delivery routes for gene therapy, and mentions the possiblity of cell therapy for ocular diseases such as geographic atrophy.

Posted: 3/07/2016

Keywords:

Gene Therapy

Up Next

Advances in Pediatric Vitreoretinal Surgery

Advances in Pediatric Vitreoretinal Surgery

R.V. Paul Chan, MD, Tim Murray, MD

VMT Management: Watch and Wait

VMT Management: Watch and Wait

Harry W. Flynn Jr., MD, Tim Murray, MD

Imaging and Uveitis: How to Apply Imaging Information

Imaging and Uveitis: How to Apply Imaging Information

Glenn Jaffe, MD, Tim Murray, MD

Macular Hole Repair in the Small-Gauge Era

Macular Hole Repair in the Small-Gauge Era

Tarek Hassan, MD, Tim Murray, MD

Update on Health Care Policy

Update on Health Care Policy

David W. Parke II, MD, Tim Murray, MD

Protocol T 2-Year Data

Protocol T 2-Year Data

Neil Bressler, MD, Tim Murray, MD

Acute Ocriplasmin Retinopathy

Acute Ocriplasmin Retinopathy

Mark Johnson, MD, Tim Murray, MD

Back to All Videos

Treatments Using Gene Therapy and Engineered Cells

Szilard Kiss, MD, Tim Murray, MD

Szilárd Kiss, MD, explains the most important portions of his presentation on ocular gene therapy to Tim Murray, MD, MBA. Dr. Kiss says that although the most immediate consequence of advancements in ocular gene therapy may affect patents with Leber congenital amaurosis, the possible benefits to patients with age-related macular degeneration and diabetic macular edema may serve large swaths of the population. Dr. Kiss also discusses the importance of delivery routes for gene therapy, and mentions the possiblity of cell therapy for ocular diseases such as geographic atrophy.

Posted: 3/07/2016

Keywords:

Gene Therapy

Please log in to leave a comment.

More From ARDS: 2016 Coverage

VMT Management: Watch and Wait

VMT Management: Watch and Wait

Harry W. Flynn Jr., MD, Tim Murray, MD

Imaging and Uveitis: How to Apply Imaging Information

Imaging and Uveitis: How to Apply Imaging Information

Glenn Jaffe, MD, Tim Murray, MD

Macular Hole Repair in the Small-Gauge Era

Macular Hole Repair in the Small-Gauge Era

Tarek Hassan, MD, Tim Murray, MD

Update on Health Care Policy

Update on Health Care Policy

David W. Parke II, MD, Tim Murray, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARDS: 2016.